BRIGHTSPIRE CAPITAL, INC. (BRSP)
BrightSpire Capital Announces $0.16 Per Share Dividend for Second Quarter 2026
BrightSpire Capital Announces $0.16 Per Share Dividend for Second Quarter 2026
Bryn Mawr Trust Advisors Elevates Leadership for Client Growth
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
XBiotech startet klinische Phase-II-Studie zur Bewertung von Vilamakitug bei der Behandlung der aktiven axialen Spondyloarthritis
XBiotech lance un essai clinique de phase II visant à évaluer le vilamakitug dans le traitement de la spondylarthrite axiale active
Meet the New Chase Sapphire Preferred: Earn More Than Ever, Same $95 Annual Fee
Celanese and Siegwerk Collaborate to Advance More Sustainable Printing Ink Solutions with Bio-Based Ethyl Acetate
NexPoint Diversified Real Estate Trust Announces Investor Update Call
JPMorganChase Expands Security and Resiliency Initiative to Canada
Principal Asset Management® Launches Fixed Income ETF Suite